Synopsis
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Chewable & Orodispersible Aids
Taste Masking
Direct Compression
Disintegrants & Superdisintegrants
Parenteral
Co-Processed Excipients
Granulation
Solubilizers
Thickeners and Stabilizers
Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
99
PharmaCompass offers a list of Daunorubicin HCl API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Daunorubicin HCl manufacturer or Daunorubicin HCl supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Daunorubicin HCl manufacturer or Daunorubicin HCl supplier.
PharmaCompass also assists you with knowing the Daunorubicin HCl API Price utilized in the formulation of products. Daunorubicin HCl API Price is not always fixed or binding as the Daunorubicin HCl Price is obtained through a variety of data sources. The Daunorubicin HCl Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Daunomycin HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Daunomycin HCl, including repackagers and relabelers. The FDA regulates Daunomycin HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Daunomycin HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Daunomycin HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Daunomycin HCl supplier is an individual or a company that provides Daunomycin HCl active pharmaceutical ingredient (API) or Daunomycin HCl finished formulations upon request. The Daunomycin HCl suppliers may include Daunomycin HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Daunomycin HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Daunomycin HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Daunomycin HCl active pharmaceutical ingredient (API) in detail. Different forms of Daunomycin HCl DMFs exist exist since differing nations have different regulations, such as Daunomycin HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Daunomycin HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Daunomycin HCl USDMF includes data on Daunomycin HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Daunomycin HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Daunomycin HCl suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Daunomycin HCl Drug Master File in Japan (Daunomycin HCl JDMF) empowers Daunomycin HCl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Daunomycin HCl JDMF during the approval evaluation for pharmaceutical products. At the time of Daunomycin HCl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Daunomycin HCl suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Daunomycin HCl Drug Master File in Korea (Daunomycin HCl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Daunomycin HCl. The MFDS reviews the Daunomycin HCl KDMF as part of the drug registration process and uses the information provided in the Daunomycin HCl KDMF to evaluate the safety and efficacy of the drug.
After submitting a Daunomycin HCl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Daunomycin HCl API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Daunomycin HCl suppliers with KDMF on PharmaCompass.
A Daunomycin HCl CEP of the European Pharmacopoeia monograph is often referred to as a Daunomycin HCl Certificate of Suitability (COS). The purpose of a Daunomycin HCl CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Daunomycin HCl EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Daunomycin HCl to their clients by showing that a Daunomycin HCl CEP has been issued for it. The manufacturer submits a Daunomycin HCl CEP (COS) as part of the market authorization procedure, and it takes on the role of a Daunomycin HCl CEP holder for the record. Additionally, the data presented in the Daunomycin HCl CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Daunomycin HCl DMF.
A Daunomycin HCl CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Daunomycin HCl CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Daunomycin HCl suppliers with CEP (COS) on PharmaCompass.
A Daunomycin HCl written confirmation (Daunomycin HCl WC) is an official document issued by a regulatory agency to a Daunomycin HCl manufacturer, verifying that the manufacturing facility of a Daunomycin HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Daunomycin HCl APIs or Daunomycin HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Daunomycin HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of Daunomycin HCl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Daunomycin HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Daunomycin HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Daunomycin HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Daunomycin HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Daunomycin HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Daunomycin HCl suppliers with NDC on PharmaCompass.
Daunomycin HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Daunomycin HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Daunomycin HCl GMP manufacturer or Daunomycin HCl GMP API supplier for your needs.
A Daunomycin HCl CoA (Certificate of Analysis) is a formal document that attests to Daunomycin HCl's compliance with Daunomycin HCl specifications and serves as a tool for batch-level quality control.
Daunomycin HCl CoA mostly includes findings from lab analyses of a specific batch. For each Daunomycin HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Daunomycin HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Daunomycin HCl EP), Daunomycin HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Daunomycin HCl USP).
